Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Emerging Healthcare Inc. Acquires China Rights to Stem Cell Technology

publication date: Dec 30, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Emerging Healthcare Solutions, Inc. of Houston has in-licensed the China rights to a system from Regenetech that cultures stem cells in a simulated weightless environment. Regenetech’s Intrifuge™ Rotary Cell Culture System was developed by NASA and licensed to Regenetech. EHSI plans to combine the stem cell culturing technology with a treatment for liver disease. More details....

Stock Symbol: (OTCPK: EHSI)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners